A detailed history of Graham Capital Management, L.P. transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 68,651 shares of CHRS stock, worth $75,516. This represents 0.0% of its overall portfolio holdings.

Number of Shares
68,651
Previous 35,481 93.49%
Holding current value
$75,516
Previous $61,000 16.39%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.99 - $1.8 $32,838 - $59,706
33,170 Added 93.49%
68,651 $71,000
Q2 2024

Aug 14, 2024

BUY
$1.58 - $2.51 $56,059 - $89,057
35,481 New
35,481 $61,000
Q3 2023

Nov 22, 2023

BUY
$3.74 - $5.45 $9,892 - $14,415
2,645 Added 2.06%
131,184 $490,000
Q2 2023

Aug 14, 2023

BUY
$3.79 - $8.3 $487,162 - $1.07 Million
128,539 New
128,539 $548,000
Q3 2022

Nov 14, 2022

BUY
$7.17 - $13.87 $597,612 - $1.16 Million
83,349 Added 42.65%
278,770 $2.68 Million
Q2 2022

Aug 15, 2022

BUY
$5.86 - $13.23 $985,095 - $2.22 Million
168,105 Added 615.41%
195,421 $1.41 Million
Q1 2022

May 16, 2022

BUY
$10.92 - $16.41 $298,290 - $448,255
27,316 New
27,316 $352,000

Others Institutions Holding CHRS

About Coherus BioSciences, Inc.


  • Ticker CHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,724,600
  • Market Cap $85.5M
  • Description
  • Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...
More about CHRS
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.